About The Position

The Senior Director, Global Analytics & Insights, Cell Therapy leads insights and analysis for AstraZeneca’s Cell Therapy Enterprise, supporting priority assets from clinical development through commercialization across prioritized disease areas. The role provides deep insights and strategic direction for enterprise-level initiatives and key commercial decisions, helping improve the quality of decisions through high-quality market, customer, and competitor analytics. The position reports to the Global Commercial Head, Cell Therapy. The role serves as the Global Analytics & Insights point of contact for the Cell Therapy Enterprise and partners with cross-functional leaders and priority markets to shape portfolio strategy, asset development plans, and long-range business planning. It builds institutional knowledge of relevant disease areas, patients, healthcare professionals, market dynamics, and competitors, and develops the evidence and market understanding needed to inform clinical development, asset prioritization, indication strategy, and future commercialization. For priority assets and indications, the Senior Director develops therapy-area expertise spanning clinical development through commercialization. The role integrates clinical, market, customer, competitor, access, and treatment-delivery insights to inform target product profiles, development choices, indication sequencing, portfolio prioritization, and forecasts. It also develops quantitative analyses and business cases that account for cell therapy-specific considerations, including eligible patient identification, referral pathways, treatment-center readiness, manufacturing capacity, vein-to-vein time, access, and scalability. The position manages external market research, forecasting, and data/analytics vendor and partner relationships and budgets, and explores advanced analytics and predictive modeling suited to cell therapy’s delivery model.

Requirements

  • Bachelor’s degree in a relevant scientific or mathematics discipline.
  • At least 6 years of analytical and market research experience in the pharmaceutical or consulting industry.
  • Excellent communication skills.
  • Experience engaging and communicating with senior executives.
  • Experience in a similar strategy role within the pharmaceutical industry or life science consulting.
  • Ability to use data and analysis to affect, influence, or change understanding of a market or customer.

Nice To Haves

  • MBA, PhD, PharmD, or another advanced degree.
  • Cell therapy, advanced therapies, or oncology development experience; described as strongly preferred.
  • At least 4 years of experience in a consulting, advisory, or investment firm working within the pharmaceutical industry.
  • Experience supporting early-stage or pre-launch assets, including indication prioritization, target product profile development, forecasting under uncertainty, and commercialization readiness.
  • Experience working in a global team.

Responsibilities

  • Act as the Global Analytics & Insights point of contact for the Cell Therapy Enterprise, partnering with cross-functional leaders and priority markets on portfolio strategy, asset development plans, and long-range business planning.
  • Build knowledge of key disease areas, including healthcare professional and patient insights, market dynamics, the competitive landscape, and implications for AstraZeneca’s portfolio.
  • Lead strategic projects across the cell therapy portfolio with Cell Therapy Enterprise leadership and cross-functional teams.
  • Build the capabilities, evidence, and market understanding needed to support clinical development plans, asset prioritization, indication strategy, and future commercialization.
  • Develop deep therapy-area knowledge bridging clinical development and commercialization for priority assets and indications.
  • Analyze patients, markets, collaborators, competitors, and brands to identify strategic insights and competitive advantage.
  • Partner with Global Commercial, R&D, Medical, Regulatory, Market Access, and Operations teams, bringing objective insights to asset and portfolio decisions.
  • Provide an independent, external, and future-oriented perspective in decision-making bodies.
  • Integrate clinical, market, customer, competitor, access, and treatment-delivery insights to inform target product profiles, development choices, indication sequencing, portfolio prioritization, and opportunity-focused forecasts.
  • Develop quantitative analyses and business cases reflecting cell therapy considerations such as eligible patient identification, referral pathways, treatment-center readiness, manufacturing capacity, vein-to-vein time, access, and scalability.
  • Manage relationships and budgets with external market research, forecasting, and data/analytics vendors and partners.
  • Explore advanced analytics and predictive modeling suited to cell therapy’s unique delivery model.

Benefits

  • Annual base pay range of $218,330 to $327,494, with offered pay varying according to individualized factors.
  • Short-term incentive bonus opportunity.
  • Eligibility to participate in the equity-based long-term incentive program for salaried roles.
  • Retirement contribution for hourly roles.
  • Commission payment eligibility for sales roles.
  • Qualified retirement program (401(k) plan).
  • Paid vacation and holidays.
  • Paid leaves.
  • Medical, prescription drug, dental, and vision coverage, subject to applicable plan terms and conditions.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service